Why the study?
Does Deslanoside-C improve diminished baroreceptor sensitivity in diabetics and normal controls?
Does Deslanoside-C improve diminished baroreceptor sensitivity in diabetics and normal controls?
Diabetics exhibit diminished baroreceptor sensitivity which can be significantly increased by the administration of digitalis (Deslanoside-C).
Answers are grounded in this paper and cite their sources.
Acute Deslanoside-C may enhance baroreceptor sensitivity in diabetics; hypothesis-generating for digitalis in autonomic dysfunction, needs prospective trials.
The baroreceptor sensitivity was estimated in 50 normal controls (Group A) and in 50 diabetics of comparable age (Group B). The technique used was infusion of angiotensin (0.5 microgram/min) and measurement of the bradycardic response resulting from the increase of blood pressure. The slope was used as an index of baroreceptor sensitivity. Diabetics had significantly lower baroreceptor sensitivity and a higher resting heart rate. Sensitivity decreased with age in both groups. The reproducibility of the method was excellent. Deslanoside-C (0.8 mg) significantly increased the baroreceptor sensitivity in 11 normal controls and 9 diabetics. Very low sensitivity was found in 26 diabetics who had no evidence of orthostatic hypotension, neuropathy, or retinopathy. However all 17 patients with the above findings had very low sensitivity.
No takes yet. Share an insight, caveat, or question.
Cokkinos et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: